# Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

> **NCT04698330** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 240 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus
- Autoimmune Diabetes

## Interventions

- **DRUG:** Berberine
- **DRUG:** Inulin
- **DRUG:** Berberine placebo tablets
- **DRUG:** Inulin placebo tablets

## Key facts

- **NCT ID:** NCT04698330
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-05
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2022-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04698330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04698330, "Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04698330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*